Summary & Overview
CPT 82044: Semiquantitative Urine Albumin (Microalbumin) by Reagent Strip
CPT code 82044 designates a semiquantitative urine albumin (microalbumin) test performed manually with a reagent strip, without use of an automated chemistry analyzer. This point-of-care diagnostic procedure is commonly used to screen for early kidney damage, monitor patients with diabetes or hypertension, and support clinical decision-making in outpatient settings. Nationally, use of this code matters because it captures low-cost, office-based screening that can influence quality metrics and population health management.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of clinical context for semiquantitative urine albumin testing, common settings where the service is provided, and what the code represents for billing and documentation. The publication summarizes typical use cases, outlines which payers are addressed, and indicates where input data were unavailable.
The report covers clinical relevance, standard sites of service, and what to expect in payor coverage discussions. It also highlights gaps where specific benchmark or taxonomy data were not provided. Data not available in the input.
Billing Code Overview
CPT code 82044 describes a semiquantitative urine albumin (microalbumin) test performed without use of a chemistry analyzer or other instrument, typically using a reagent strip read visually by office or laboratory personnel. This service is generally performed as a point-of-care or walk-in test.
-
Service type: Point-of-care or office-based diagnostic urine testing
-
Typical site of service: Physician office, outpatient clinic, or laboratory performing manual reagent-strip urinalysis
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 58-year-old adult with type 2 diabetes mellitus presenting to a primary care clinic for an annual diabetes visit. As part of routine monitoring for diabetic nephropathy, office staff perform a semiquantitative urine albumin (microalbumin) test using a reagent strip at point of care. The workflow: the clinician orders urine testing during the visit; a clean-catch urine specimen is collected; clinical staff dip the reagent strip and read the result visually or with a small strip reader; results are documented in the medical record; a normal or negative result requires routine follow-up, while a positive or abnormal semiquantitative result prompts repeat testing, confirmation with a quantitative urine albumin-to-creatinine ratio, or nephrology referral as clinically indicated. Typical site of service is an outpatient physician office or clinical laboratory where no central chemistry analyzer is required.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day | Use when a separately reportable E/M visit is provided the same day as 82044 and documentation supports a distinct E/M service. |
26 |